First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group and crypto investment firm GSR.

The move includes the appointment of Charlie Lee, the creator of Litecoin, to MEI’s Board of Directors.

The Litecoin Foundation has also taken an investment position in MEI as part of the initiative.

The company’s stock rose sharply from $4.20 to $11.45 following the announcement, before retracing to $6.00, reflecting market volatility after a significant change in strategic direction.

“For 14 years, Litecoin has consistently delivered a stable, low-cost, and …

Full story available on Benzinga.com